NCT05716841

Effects of Ballistic Exercises on Pain, Disability, and Explosive Strength in Tennis Players With Shoulder Pain.

Completed NA Last updated 14 August 2023

What this trial tests

NA trial testing Ballistic exercises in Shoulder Pain in 16 participants. Completed in 30 July 2023.

Timeline

17 January 2023

Primary endpoint
30 June 2023

30 July 2023

Quick facts

Lead sponsor	Sehat Medical Complex
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	16
Start date	17 January 2023
Primary completion	30 June 2023
Estimated completion	30 July 2023
Sites	1 location across Pakistan

Drugs / interventions tested

• Ballistic exercises

Conditions studied

• Shoulder Pain — all drugs for Shoulder Pain →

Sponsor

Sehat Medical Complex

Who can join

Adults 18 to 35, any sex, with Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this Randomized control trial is to determine ''Effects of ballistic exercises on pain, disability and explosive strength in tennis players with shoulder pain''. The main question it aims to answer is:

To determine effect of ballistic exercises on pain, disability and explosive strength in tennis players with shoulder pain.

Participants will be divided into 2 groups. Group-A will be treated with stretching and simple baseline strengthening of the upper limb through any regular mean (like TheraBand) in a moderate manner with 10 to 20 repetitions for 3 days per week for six weeks. Group B will be treated with stretching and then strengthening of the upper limb through ballistic six exercises from a moderate to intense manner with 3 sets of 10 repetitions with a 30sec gap between sets, 3 sets of 15 repetitions with a 30sec gap between sets, and 3 sets of 20 repetitions with a 30sec gap between sets for 3 to 4 days per week for six weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.